Regener-Eyes opens Chapter 11 in Tampa
Regener-Eyes LLC filed a voluntary Chapter 11 case on April 3, 2026 in the Middle District of Florida, Tampa division, case number 8:26-bk-02780-RCT, according to Bankruptcyobserver. The petition disclosure reported both assets and liabilities in the $10 million to $50 million range, putting the case in a middle-market restructuring band where recoveries and operating runway will depend heavily on first-day liquidity, claims control, and any regulatory-driven business constraints.
The company makes Regener-Eyes ophthalmic products, so professionals should track whether the case becomes an operating reorganization, a sale process, or a claims-management proceeding tied to product and regulatory issues. The first docket activity includes the petition, an order authorizing the debtor to operate as debtor-in-possession, and a joint-administration motion noted by Bkdata, but the trigger does not provide filing-backed terms for DIP financing or any sale process yet.